Ignite Creation Date:
2025-12-26 @ 10:46 PM
Ignite Modification Date:
2025-12-26 @ 10:46 PM
Study NCT ID:
NCT05514912
Status:
WITHDRAWN
Last Update Posted:
2023-12-26
First Post:
2022-08-19
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Preoperative Nab-paclitaxel, Cisplatin, and Gemcitabine Chemotherapy With or Without Infigratinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, The OPTIC Trial
Sponsor:
Emory University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-06-23
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-06-23
Completion Date Type:
ESTIMATED
First Submit Date:
2022-08-19
First Submit QC Date:
None
Study First Post Date:
2022-08-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-20
Last Update Post Date:
2023-12-26
Last Update Post Date Type:
ACTUAL